(1) Background: When implementing new biomechanical and technology-based assessments, such as the jump assessment in Multiple Sclerosis (MS), into clinical routine, it is important to ensure that they are based on the real needs of patients and to identify and adapt to potential barriers early on. (2) Methods: In the present cross-sectional study, 157 pwMS performed a sensor-based jump assessment on a force plate consisting of three jump tests: 10 s jump test (10SHT), countermovement jumps (CMJ), and single-leg countermovement jumps (SLCMJ). After the jump assessment, the patient experience measures (PREM) were recorded using a paper-based questionnaire on an 11-point scale from 0 (positive) to 10 (negative). (3) Results: PwMS showed an overall positive experience with the sensor-based jump assessment. “Staff support performance”, “acceptance required time”, “usefulness” of the results, and “integration of results in therapy” were the best rated items with a median of 0 (positive). The CMJ was perceived as the easy (p < 0.05) and less exhausting (p < 0.05). PwMS who experienced CMJ as easy, not exhausting, and safe were associated with higher CMJ performance, especially in peak power, flight time, and jump height (r > −0.4). Significant associations were found between PREMs and age, sex, BMI, physical activity, and disability degree. (4) Conclusions: The study findings support the feasibility of jump assessment in clinical practice and highlight the need for patient-centered integration of innovative technologies to optimize precision neuromuscular function evaluation in MS.

Background: Immersive virtual reality (VR) has emerged as a promising tool for standardized, engaging assessment of motor and cognitive function in people with multiple sclerosis (pwMS). However, patient-reported experiences with immersive VR tasks have not been systematically evaluated. Objective: To characterize patient-reported experience measures (PREMs) after a multidomain immersive VR task and explore relationships with clinical characteristics, therapeutic history, and task performance. Methods: In this prospective cross-sectional study, participants completed a seated immersive VR task comprising six upper-limb tasks with motor and cognitive components. Patient experience was evaluated immediately afterward using a PREM questionnaire. Upper-limb activity limitations were assessed with the Arm Function in Multiple Sclerosis Questionnaire (AMSQ). Results: A total of 129 pwMS (EDSS 3.5–8.0) participated. Median PREM item scores ranged from 1.0 to 2.0 (scale 0–10), indicating an overall positive experience. Over 80% rated staff support as excellent; more than half perceived the assessment as safe, comfortable, and appropriately timed. An amount of 40.3% of pwMS wished to use VR tasks more often than once per year. PwMS receiving upper-limb physiotherapy or occupational therapy reported greater perceived difficulty than those without therapy. In exploratory analyses, higher perceived difficulty and a preference for less frequent VR use were associated with higher EDSS (r = 0.208 and 0.200) and ambulation scores (r = 0.215 and 0.195). Difficulty ratings were also related to pyramidal (r = 0.188) and sensory (r = 0.174) impairments. Conclusions: PwMS reported a positive overall experience with the immersive VR tasks. Further studies should evaluate the suitability and validity of this approach compared with conventional assessments.